Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
June 07 2022 - 6:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will take part in a fireside chat at Goldman Sachs’ 43rd
Annual Global Healthcare Conference in Rancho Palos Verdes,
California on Wednesday, June 15, 2022. Adam Lenkowsky, Senior Vice
President and General Manager, U.S. Commercialization, will answer
questions about the company at 9:20 a.m. PT/12:20 p.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Material related
to the company’s presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
CorporateFinancial-News
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220607005304/en/
Bristol Myers Squibb Media: media@bms.com Investor
Relations: investors@bms.cominvestor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024